Detection of NRG1 Fusions in Solid Tumors: Rare Gold?
Fusions between NRG1 and partner genes are rare, tumorigenic genomic events occurring in patients with lung and other cancers, associated with activation of ERBB2/ERBB3 heterodimers. Inhibition of ERBB2 and/or ERBB3 in this group of patients is a promising strategy in clinical trials.See related article by Jonna et al., p. 4966.